Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueGross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - OtherRevenue - OtherShares IssuedShares OutstandingShares OutstandingShort-Term Debt repayments
Ratios

InflaRx (IFRX) Receivables - Other (2025)

InflaRx's Receivables - Other history spans 1 years, with the latest figure at $2.9 million for Q4 2025.

  • On a quarterly basis, Receivables - Other changed N/A to $2.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.9 million, a N/A change, with the full-year FY2025 number at $2.9 million, changed N/A from a year prior.
  • Receivables - Other hit $2.9 million in Q4 2025 for InflaRx.
  • Over the last five years, Receivables - Other for IFRX hit a ceiling of $2.9 million in Q4 2025 and a floor of $2.9 million in Q4 2025.